טבימברה - Tevimbra

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)

L01FF
PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors

××¨××× ×¤×¢×× (ATC5)

TISLELIZUMAB 10 MG/ML âL01FF09

×¦××¨×ª ××ª×

×ª××-××¨××× - I.V

×¦××¨×ª ××× ××

×ª×¨××× ×××× ×ª ×ª×××¡× ×××× ×¤××××, CONCENTRATE FOR SOLUTION FOR INFUSION
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

19/02/2025

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª
×. ××©×××× ×¢× ×××××ª×¨×¤××, ××§× ×××¤×× ×¨××©×× ××¡×¨×× ×¨××× ××¨××¨×ª× ××¡×× Squamous NSCLC, ×××××× ×©××× × ×××××× ××××¦×××ª ××¡×× EGFR, ALK, ROS1. ×. ××××× ××××ª× ×××× ××××× ×××× ××ª×¨××¤× ×××ª ×××× ××ª×¨××¤××ª ×××©×ª×××××ª ×××©×¤××ª ×-Checkpoint inhibitors. ×. ××ª× ××ª×¨××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ××××× ×××× ×§××××××.	19/02/2025	××× ×§××××××		Squamous cell NSCLC

××¡××¨×ª ××××× ××¡×

××©×××× ×¢× ×××××ª×¨×¤××, ××§× ×××¤×× ×¨××©×× ××¡×¨×× ×¨××× ××¨××¨×ª× ××¡×× Squamous NSCLC, ×××××× ×©××× × ×××××× ××××¦×××ª ××¡×× EGFR, ALK, ROS1

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

Â ××× ×¢××× ××¨××¤× Â

×¢××× ××¦×¨××	Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××××××¨× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	BEIGENE SWITZERLAND GMBH, SWITZERLAND
×©× ××¢× ××¨××©××	BEIGENE PHARMACEUTICALS ISRAEL LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 6/2023. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	14/09/2024

השינוי האחרון נעשה בֹ־28 באוגוסט 2025 ב־16:13

טבימברה - Tevimbra

ויקיתרופות